FS Development Corp II Cl A (FSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FSII | TLSA | ARCT | ||
| Company | FS Development Corp II Cl A | Tiziana Life Sciences Ltd | Arcturus Therapeutics Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.05 | 1.7400 | 6.85 | ||
| High | 10.16 | 1.7800 | 7.19 | ||
| Low | 9.69 | 1.6900 | 6.84 | ||
| Latest | 9.80 | 1.7400 | 7.13 | ||
| Change | -0.20 | -0.0300 | +0.30 | ||
| % Change | -2.00% | -1.69% | +4.39% | ||
| Volume | 289,100 | 158,000 | 1,362,500 | ||
| 20-Day Average Volume | 227,795 | 243,460 | 944,240 | ||
| Previous Close | 10.00 | 1.7700 | 6.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.86 | 1.7407 | 7.05 | ||
| 20-Day Raw Stochastic | 2.99% | 56.76% | 37.21% | ||
| 20-Day Relative Strength | 38.90 | 46.85 | 36.75 | ||
| Weighted Alpha | -13.88 | +9.93 | -63.99 | ||
| Today's Opinion | 8% Buy | 24% Sell | 72% Sell | ||
| Previous Opinion | 8% Buy | 8% Buy | 88% Sell | ||
| Last Month's Opinion | 72% Buy | 48% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.89% since 12/16/21 | -3.33% since 11/28/25 | +5.01% since 11/28/25 | ||
| Low | 9.64 on 12/21/21 | 1.6200 on 12/04/25 | 6.07 on 12/02/25 | ||
| High | 10.86 on 12/21/21 | 1.9000 on 12/02/25 | 7.19 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | -30.10% since 11/23/21 | -5.43% since 11/05/25 | -17.48% since 11/05/25 | ||
| Low | 9.64 on 12/21/21 | 1.5300 on 11/21/25 | 5.85 on 11/20/25 | ||
| High | 15.00 on 12/01/21 | 1.9000 on 12/02/25 | 9.29 on 11/11/25 | ||
| 3-Month | |||||
| %Chg | -1.90% since 09/23/21 | +4.82% since 09/05/25 | -60.06% since 09/05/25 | ||
| Low | 9.64 on 12/21/21 | 1.5300 on 11/21/25 | 5.85 on 11/20/25 | ||
| High | 15.05 on 11/19/21 | 2.3500 on 09/25/25 | 24.17 on 10/21/25 | ||
| 6-Month | |||||
| %Chg | -0.81% since 06/23/21 | +23.40% since 06/05/25 | -40.13% since 06/05/25 | ||
| Low | 9.64 on 12/21/21 | 1.3500 on 06/11/25 | 5.85 on 11/20/25 | ||
| High | 15.05 on 11/19/21 | 2.6000 on 08/01/25 | 24.17 on 10/21/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 203,125 | 203,316 | 202,585 | ||
| Shares Outstanding, K | 20,727 | 116,848 | 28,413 | ||
| Annual Sales | 0 | 0 | 152,310,000 | ||
| Annual Net Income | 0 | -11,860,000 | -80,940,000 | ||
| Last Quarter Sales | 0 | N/A | 17,150,000 | ||
| Last Quarter Net Income | -1,220,000 | N/A | -13,450,000 | ||
| 60-Month Beta | N/A | -0.05 | 2.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/12/21 | N/A | -0.49 on 11/10/25 | ||
| Latest Earnings Date | 10/16/12 | 08/05/25 | 11/10/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 01/04/13 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||